Trial · NCT01074944
Participant flow60
How many started, completed or left each group, period by period.
1 to 20 of 60
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Lead-in Period (up to 78 Weeks) | STARTED | LIP, Eliglustat | 170 | |
| Lead-in Period (up to 78 Weeks) | STARTED | PAP, Eliglustat: Once Daily | 0 | |
| Lead-in Period (up to 78 Weeks) | STARTED | PAP, Eliglustat: Twice Daily | 0 | |
| Lead-in Period (up to 78 Weeks) | STARTED | LTTP, Eliglustat | 0 | |
| Lead-in Period (up to 78 Weeks) | STARTED | ETP, Eliglustat | 0 | |
| Lead-in Period (up to 78 Weeks) | COMPLETED | LIP, Eliglustat | 157 | |
| Lead-in Period (up to 78 Weeks) | COMPLETED | PAP, Eliglustat: Once Daily | 0 | |
| Lead-in Period (up to 78 Weeks) | COMPLETED | PAP, Eliglustat: Twice Daily | 0 | |
| Lead-in Period (up to 78 Weeks) | COMPLETED | LTTP, Eliglustat | 0 | |
| Lead-in Period (up to 78 Weeks) | COMPLETED | ETP, Eliglustat | 0 | |
| Lead-in Period (up to 78 Weeks) | NOT COMPLETED | LIP, Eliglustat | 13 | |
| Lead-in Period (up to 78 Weeks) | NOT COMPLETED | PAP, Eliglustat: Once Daily | 0 | |
| Lead-in Period (up to 78 Weeks) | NOT COMPLETED | PAP, Eliglustat: Twice Daily | 0 | |
| Lead-in Period (up to 78 Weeks) | NOT COMPLETED | LTTP, Eliglustat | 0 | |
| Lead-in Period (up to 78 Weeks) | NOT COMPLETED | ETP, Eliglustat | 0 | |
| Primary Analysis Period (up to 52 Weeks) | STARTED | LIP, Eliglustat | 0 | |
| Primary Analysis Period (up to 52 Weeks) | STARTED | PAP, Eliglustat: Once Daily | 65 | |
| Primary Analysis Period (up to 52 Weeks) | STARTED | PAP, Eliglustat: Twice Daily | 66 | |
| Primary Analysis Period (up to 52 Weeks) | STARTED | LTTP, Eliglustat | 0 | |
| Primary Analysis Period (up to 52 Weeks) | STARTED | ETP, Eliglustat | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01074944/flow